Carcinoma, Squamous Cell: all 1,779 studies

Page 3 of 18. Open to participants first (409), then studies with results posted, then the rest; newest registration first within each.

• Artesunate Ointment for the Treatment of Anal HSIL in HIV-negative ParticipantsRecruitingNCT06206564Phase 2
• Alpha Radiation Emitters Device for the Treatment of Primary and Recurrent Squamous Cell Carcinoma of the Vulva (DaRT).Not yet recruitingNCT06202339Not applicable
• Study of the Role of Oncostatin M in Head and Neck Squamous Cell CarcinomaNot yet recruitingNCT06199947Not applicable
• Neoadjuvant Adebrelimab Plus Dalpiciclib in Head and Neck Squamous Cell CarcinomaNot yet recruitingNCT06199271Phase 2
• A Study of KC1036 Versus Investigator's Choice of Chemotherapy in Patients With Advanced Esophageal CancerRecruitingNCT06194734Phase 3
• Oral Microbiome is Associated With the Response to Chemoradiotherapy in Initial Inoperable Patients With Esophageal Squamous Cell CancerRecruitingNCT06190847
• Local Therapy for Oligometastatic ESCC Patients Treated With PD-1 InhibitorRecruitingNCT06190782Phase 3
• A Clinical Study of Sintilimab as Adjuvant Therapy in Node-positive ESCCRecruitingNCT06190639Phase 2
• Consolidation of Toripalimab After Chemoradiotherapy in Elderly Esophageal Cancer (EC-CRT-007)RecruitingNCT06187597Phase 2
• Validity of Viome's Oral/throat Cancer TestRecruitingNCT06174428
• Immunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal CancerRecruitingNCT06173986Phase 1/2
• Postoperative CCRT Followed by Immunotherapy in High-Risk LA HNSCCRecruitingNCT06170710Phase 2
• Advanced First-line Treatment of Short-term Postoperative Progression of Head and Neck Squamous Cell CarcinomaRecruitingNCT06170697Phase 2
• Assessment of the Effect of Tumor Thickness and Site on Level IV Cervical Lymph Nodes in Squamous Cell Carcinoma of the Tongue and Floor of the Mouth: A Case Series StudyRecruitingNCT06169605Not applicable
• Postoperative Immune Maintenance Therapy for Esophageal Squamous Cell Carcinoma After Radical ResectionNot yet recruitingNCT06161909Phase 3
• A Clinical Study of Non-curative Resection Plus Radiotherapy After Endoscopic ESD for Superficial Esophageal Squamous Cell CarcinomaEnrolling by invitationNCT06160557
• A Perioperative Sintilimab and Chemotherapy in Esophageal Squamous Cell CarcinomaNot yet recruitingNCT06152978Phase 2
• Synchronous or Sequential Radiotherapy for Advanced Esophageal Squamous Cell Carcinoma With Oligometastases.Not yet recruitingNCT06143722Phase 2
• Pirfenidone as a Radiosensitizer in the Treatment of Head and Neck Squamous Cell CarcinomaRecruitingNCT06142318Phase 2
• A New Mutational and Epigenetic Signature to Predict Early OPSCC RelapseRecruitingNCT06138483
• Phase 2 Trial of Adaptive Radiotherapy Boost for HNSCCRecruitingNCT06137274Phase 2
• A Study of Docetaxel for Injection (Albumin-bound) and SG001 in Combination With Cisplatin and Simultaneous Radiotherapy for Locally Advanced Unresectable Esophageal Squamous Carcinoma.Not yet recruitingNCT06136988Phase 1/2
• Neoadjuvant Tirellizumab Combined With Chemotherapy for Early Oral Squamous Cell Carcinoma(HNC-SYSU-004)RecruitingNCT06130332Phase 2
• A Prospective, Single-arm Phase II Clinical Trial of Tislelizumab Combined With Platinum Doublet Neoadjuvant Therapy to Improve Mandibular Preservation in Resectable Locally Advanced Oral Squamous Cell Carcinoma.Not yet recruitingNCT06130007Phase 2
• Trajectory Analysis of NLR and Its Association With Efficacy of Immunochemotherapy in ESCC.RecruitingNCT06125262
• PABLIXIMAB as Neoadjuvant Therapy for Head and Neck Squamous-cell CarcinomaNot yet recruitingNCT06125223
• Optimization of Treatment Strategy for Unresectable cN3 Esophageal Squamous Cell CarcinomaRecruitingNCT06122493Phase 2
• Cetuximab+Zimberelimab in Combination With Cisplatin and Nab-paclitaxel in Resctable Head and Neck Squamous Cell CarcinomaNot yet recruitingNCT06107114Phase 2
• Dynamic ctDNA Monitoring in Neoadjuvant Therapy for Esophageal Squamous Cell CarcinomaRecruitingNCT06103890
• Efficacy and Safety of Netupitant and Palonosetron Hydrochloride Capsules in Preventing Nausea and Vomiting Induced by Radiochemotherapy in Head and Neck Squamous Cell CarcinomaNot yet recruitingNCT06102447Not applicable
• Toripalimab in Combined With Cetuximab，Chemotherapy for Conversion Therapy of Locally Nonresectable OCSCCRecruitingNCT06081582Phase 2
• IBI110 Combined With Sintilimab in Second-line Advanced or Metastatic Esophageal Squamous Cell Carcinoma(ESCC)Not yet recruitingNCT06078657Phase 2
• A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell CarcinomaRecruitingNCT06064877Phase 3
• Perioperative Tislelizumab Plus Chemotherapy for Resectable Thoracic Oesophageal Squamous Cell CarcinomaRecruitingNCT06056336Phase 2
• A Clinical Study of Chemoradiotherapy Sequential Fluzoparib in Pan-solid TumorsNot yet recruitingNCT06055166Phase 2
• DV Combined With PD-1 and Platinum-based First-line Treatment in Patients With HER2 IHC2+/3+ ESCCNot yet recruitingNCT06055153Phase 1/2
• Carrelizumab Combined With Concurrent Radiotherapy and Chemotherapy for Unresectable Esophageal Squamous Cell CarcinomaEnrolling by invitationNCT06048926Not applicable
• Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain MetastasisRecruitingNCT06047379Phase 1/2
• Adelbelimab Combination Chemotherapy in Neoadjuvant Therapy for Squamous Cell Carcinoma of the Head and NeckNot yet recruitingNCT06016413Phase 2
• Using Vitamin D to Reduce Oral Mucosal Inflammation in Chemotherapy Patients With Oral Squamous Cell CarcinomaRecruitingNCT06016400Phase 2/3
• Real-world Analysis on the Efficacy and Safety of Neoadjuvant Therapy for Head and Neck Squamous Cell Carcinoma （neoHNSCC）RecruitingNCT06011993
• Fruquintinib as First Line Treatment in Patients With Recurrent Esophageal Squamous Cell CarcinomaNot yet recruitingNCT06010212Phase 1/2
• ARTEMIS-006: HS-20093 in Patients With Head and Neck Squamous Cell Carcinoma and Other Solid TumorsRecruitingNCT06007729Phase 2
• Neoadjuvant Therapy for Stage II-IVA Resectable Esophageal Squamous CellRecruitingNCT06006650Phase 2
• Personalized, Adaptive Treatment for Locally Advanced Head and Neck CancerRecruitingNCT06005324Phase 1
• Neoadjuvant PD-1 Inhibitor Combined With Cetuximab in Operable Locally Advanced HNSCCNot yet recruitingNCT05993858Phase 2
• Cadonilimab/Anlotinib in Locally Advanced or Relapsed/Metastatic ESCC Patients After Failure of PD-1 Combined With Platinum-containing ChemotherapyRecruitingNCT05990231Phase 2
• Adjuvant Chemotherapy in Combination With Tislelizumab in Lymph Node-Positive Esophageal Squamous Cell CarcinomaRecruitingNCT05984342Phase 1
• A Non-interventional Study With Advanced Lung Squamous Cell CarcinomaRecruitingNCT05984017
• Prediction of Lymph Node Status in Stage T1 Esophageal Squamous Cell Carcinoma（RENMIN-237）RecruitingNCT05980403
• Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer PatientsAvailableNCT05974410
• Calizumab Combined With Bevacizumab and Capecitabine in the Treatment of Head and Neck Squamous Cell CarcinomaNot yet recruitingNCT05965154Phase 2
• Temporal Diffusion Spectroscopy MRI in Predicting the CPS of PD-L1 Expression and the Efficacy of Neoadjuvant TherapyRecruitingNCT05964595
• Nivolumab Combined With Chemotherapy in the Treatment of Primary Tracheal Squamous Cell CarcinomaRecruitingNCT05964101Phase 2
• Nicotinamide Chemoprevention for Keratinocyte Carcinoma in Solid Organ Transplant Recipients - Pivotal TrialRecruitingNCT05955924Phase 3
• Neoadjuvant Treatment of Cadonilimab Combined Albumin-paclitaxel, Cisplatin and Fluorouracil for Resectable Locally Advanced Esophageal Squamous Cell CarcinomaRecruitingNCT05947201Phase 2
• Tirelizumab in Combination With Carboplatin and Albumin-binding Paclitaxel for Neoadjuvant Therapy in HNSCCRecruitingNCT05941338Phase 2
• Topical Ascorbic Acid for Treatment of Squamous Cell Skin CancerRecruitingNCT05932511Early Phase 1
• Patient Perspectives in Squamous Cell Carcinoma Clinical TrialsNot yet recruitingNCT05929547
• XH-30002 Capsule Combined With Afatinib Tablets for the Treatment of Squamous Cell CarcinomaNot yet recruitingNCT05927844Phase 1
• WORST PATTERN OF INVASION IN ORAL SQUAMOUS CELL CARCINOMARecruitingNCT05927220
• A Study of Chemoradiation in Combination with Tislelizumab As First Line Treatment in Participants with Advanced Esophageal Squamous Cell CarcinomaRecruitingNCT05919030Phase 3
• A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell CancersRecruitingNCT05910827Phase 1/2
• Differential Mobility Spectrometry (DMS) Based Oral Tumor AnalysisRecruitingNCT05902455
• Efficacy Evaluation and Recurrence Monitoring of Therapy for Esophageal Squamous Cell Carcinoma Based on ctDNA-MRD.Not yet recruitingNCT05900583
• Candonilimab (AK104) Plus Preoperative Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma (ESCC)Not yet recruitingNCT05896787Phase 2
• Influence Mechanism of Tumor Microenvironment Changes on Neoadjuvant Therapy for Esophageal Squamous Cell CarcinomaRecruitingNCT05894369
• Carrilizumab Combined With White Purple for Squamous Cell Carcinoma of SkinRecruitingNCT05886140Not applicable
• TPExtreme Induced Chemotherapy Followed by Surgery and Radiotherapy in the Oral Carcinoma.RecruitingNCT05872880
• Palbociclib Combined With Afatinib for Advanced Squamous Carcinoma of Esophagus or Gastroesophageal JunctionRecruitingNCT05865132Phase 2
• Neoadjuvant Treatment of Tislelizumab Combined Chemotherapy for Locally Advanced Oral Squamous Cell Carcinoma ：A Single-arm, Prospective, Phase II TrialRecruitingNCT05862168Phase 2
• Neoadjuvant Radiotherapy Combined With Toripalimab for Locally Advanced Head and Neck Squamous Cell CarcinomaNot yet recruitingNCT05861557Phase 2
• A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor CancerRecruitingNCT05859074Phase 1
• COrSIcA: Disease MeasurementNot yet recruitingNCT05858021
• The Efficacy and Safety of De-escalated Postoperative Radiotherapy in Locally Advanced HNSCC With pCR/MPRRecruitingNCT05854823Not applicable
• Buccal Cancer Resection Ultrasound GuidedNot yet recruitingNCT05852665Not applicable
• 3D Ultrasound, Specimen Examination by Surgeon, and MRI in Surgical Margin AssessmentNot yet recruitingNCT05843032Not applicable
• Intratumoral Gemcitabine, Paclitaxel, Carboplatine and Intravenous Nivolumab for Locally Recurrence of Head and Neck CancersNot yet recruitingNCT05835804Phase 2
• Cadonilimab in Combination With Chemotherapy for Locally Advaced Esophageal Squamous Cell CarcinomaNot yet recruitingNCT05833971Phase 2
• Whole-course Immunonutrition Combined With Chemoradiotherapy±ICIs for Local Advanced Patients With Inoperable Esophageal Squamous Cell CarcinomaRecruitingNCT05833594
• The Effect of Nitozumab in the Treatment of Head and Neck Squamous Cell CarcinomaRecruitingNCT05831930Early Phase 1
• The Effect of Prebiotic Inulin on Patients Affected by R/M HNSCC Treated With Immune Checkpoint InhibitorsRecruitingNCT05821751Not applicable
• Elective vs Therapeutic Neck Dissection in Treatment of Patients With Clinical T1/2N1M0 Oral Squamous Cell CarcinomaNot yet recruitingNCT05806073Not applicable
• Neoadjuvant Toripalimab Plus Nimotuzumab in Oral Squamous Cell Carcinoma Prior to Radical TherapyNot yet recruitingNCT05803915Phase 2
• Immunotherapy After Radiotherapy in Elderly ESCCNot yet recruitingNCT05791136Phase 2
• A Clinical Trial of TQB2618 Injection Combined With Penpulimab Injection and Chemotherapy Versus Penpulimab Injection Combined With Chemotherapy in First-line Treatment of Relapsed/Metastatic Head and Neck Squamous Cell CarcinomaRecruitingNCT05783921Phase 1/2
• A Study of Endostar Combined With Chemotherapy and Immunotherapy in Lung Squamous Cell CarcinomRecruitingNCT05782764Phase 4
• IMM2520, a PD-L1 and CD47 Bispecific Antibody in Patients With Advanced Solid TumorsRecruitingNCT05780307Phase 1
• The Role of ctDNA Testing Plus AI-based Pathology in Resectable LSCCRecruitingNCT05778253
• Comparison of Chemoradiotherapy and Chemoradiotherapy Combined With Consolidation Chemotherapy for ESCCRecruitingNCT05775419Not applicable
• Toripalimab Maintenance for Locally Advanced Head and Neck Squamous Cell CarcinomaNot yet recruitingNCT05773079Phase 2
• A Study of IO Plus Radiotherapy in Patients With Advanced ESCC.RecruitingNCT05760391Not applicable
• An Exploratory Study of ctDNA-MRD in Predicting the Efficacy of Esophageal Squamous Cell CarcinomaNot yet recruitingNCT05759325
• Immunotherapy With CCRT Followed by Surgery for Locally Advanced ESCC PatientsRecruitingNCT05743504Phase 1/2
• Neoadjuvant Anti-PD-1 Plus Chemotherapy in Locally Advanced Resectable Esophageal Squamous Cell CarcinomaRecruitingNCT05740995
• PD-1 Antibody Combined With mXELIRI Versus mXELIRI in the Second-line Setting for ESCCRecruitingNCT05737563Phase 3
• SBRT Combined With AK104 to Treatment Relapsed or Metastatic ESCCNot yet recruitingNCT05732662Phase 2
• Survival and Prognostic Factors of Squamous Cell Carcinoma of the Nasal VestibuleRecruitingNCT05693116
• Monitoring and Early Response Evaluation Using HPV DNA - A Study on Patients With HPV-positive Throat Cancer (MER-HPV)RecruitingNCT05649865
• Liquid Biopsy for Early DiagNosis of Squamous Cell Carcinoma of the HeAd and NeCk rEgionRecruitingNCT05645783

← Carcinoma, Squamous Cell overview